سعر كونفاليبتيك 400 مجم 21 قرص 2022

Convaliptic 400 mg 21 f.c. tabs.: Retigabine (ezogabine) 400 mg (Liptis).

• Historically used as adjunctive treatment of partial-onset seizures in adults when other options inadequate (ingredient-level / withdrawn labels). Confirm current Egyptian authorization and leaflet before use.Population: Adults historicallyPubChem (NCBI), WHO ATC/DDD Index (atcddd.fhi.no)

• Hypersensitivity to retigabine/ezogabine; exact current Egyptian contraindications not verified from an opened Egyptian leaflet.General active-ingredient information · PubChem (NCBI)

• Historical regulatory actions cited risks including retinal pigmentary abnormalities, blue skin discoloration, urinary retention, and psychiatric effects; product withdrawn in US/EU markets — extreme caution and specialist oversight required if still used (ingredient-level context).General active-ingredient information · PubChem (NCBI)

• Pregnancy risk not established from a current opened label; avoid unless specialist judges benefit outweighs risk (ingredient-level limitation).General active-ingredient information · PubChem (NCBI)

• Retigabine: Activates KCNQ (Kv7) voltage-gated potassium channels, stabilizing resting membrane potential and reducing neuronal excitability (ingredient-level).